These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 36164567)

  • 1. Phosphodiesterase inhibitor for heart failure with preserved ejection fraction: A systematic review and meta-analysis.
    Chen Z; Zhao K; Xiao C; He Z; Liu S; Wu X; Shi S; Guo Y
    Saudi Pharm J; 2022 Aug; 30(8):1079-1087. PubMed ID: 36164567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis.
    De Vecchis R; Cesaro A; Ariano C; Giasi A; Cioppa C
    J Clin Med Res; 2017 Jun; 9(6):488-498. PubMed ID: 28496549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction: key role of the right heart.
    Rieth AJ; Richter MJ; Tello K; Gall H; Ghofrani HA; Guth S; Wiedenroth CB; Seeger W; Kriechbaum SD; Mitrovic V; Schulze PC; Hamm CW
    Clin Res Cardiol; 2022 Apr; 111(4):393-405. PubMed ID: 34110459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis.
    Guazzi M; Bandera F; Pelissero G; Castelvecchio S; Menicanti L; Ghio S; Temporelli PL; Arena R
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1373-81. PubMed ID: 23997100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
    Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
    Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure.
    Legris V; Thibault B; Dupuis J; White M; Asgar AW; Fortier A; Pitre C; Bouabdallaoui N; Henri C; O'Meara E; Ducharme A;
    ESC Heart Fail; 2022 Feb; 9(1):450-464. PubMed ID: 34953062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study.
    Belyavskiy E; Ovchinnikov A; Potekhina A; Ageev F; Edelmann F
    BMC Cardiovasc Disord; 2020 Sep; 20(1):408. PubMed ID: 32912157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes.
    Guazzi M; Dixon D; Labate V; Beussink-Nelson L; Bandera F; Cuttica MJ; Shah SJ
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt B):1211-1221. PubMed ID: 28412423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mineralocorticoid receptor antagonists on left ventricular diastolic function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Kamiya T; Ohte N
    Heart Vessels; 2019 Apr; 34(4):597-606. PubMed ID: 30315496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right Ventricular-Vascular Uncoupling Predicts Pulmonary Hypertension in Clinically Diagnosed Heart Failure With Preserved Ejection Fraction.
    Chen ZW; Chung YW; Cheng JF; Huang CY; Chen SY; Lin LY; Lai HC; Wu CK
    J Am Heart Assoc; 2024 Jan; 13(1):e030025. PubMed ID: 38156457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis.
    De Vecchis R; Cesaro A; Ariano C
    Minerva Cardioangiol; 2018 Oct; 66(5):659-670. PubMed ID: 28398017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Kamiya T; Ohte N
    Heart Fail Rev; 2019 Jul; 24(4):535-547. PubMed ID: 31032533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Ivabradine on Left Ventricular Diastolic Function, Exercise Tolerance and Quality of Life in Patients With Heart Failure: A Systemic Review and Meta-Analysis of Randomized Controlled Trials.
    Koroma TR; Samura SK; Cheng Y; Tang M
    Cardiol Res; 2020 Feb; 11(1):40-49. PubMed ID: 32095195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Gorter TM; Hoendermis ES; van Veldhuisen DJ; Voors AA; Lam CS; Geelhoed B; Willems TP; van Melle JP
    Eur J Heart Fail; 2016 Dec; 18(12):1472-1487. PubMed ID: 27650220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of exercise capacity in patients with heart failure without left ventricular hypertrophy.
    Ishizaka S; Iwano H; Tsujinaga S; Murayama M; Tsuneta S; Aoyagi H; Tamaki Y; Motoi K; Chiba Y; Tanemura A; Nakabachi M; Yokoyama S; Nishino H; Okada K; Meyers BA; Vlachos PP; Sato T; Kamiya K; Watanabe M; Kaga S; Nagai T; Oyama-Manabe N; Anzai T
    J Cardiol; 2023 Jan; 81(1):33-41. PubMed ID: 36122643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of right ventricular dysfunction on the effectiveness of beta-blockers in heart failure with preserved ejection fraction.
    Harada D; Asanoi H; Noto T; Takagawa J
    J Cardiol; 2020 Oct; 76(4):325-334. PubMed ID: 32475652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular performance in patients with heart failure with mildly reduced ejection fraction: the forgotten ventricle.
    Koutsampasopoulos K; Vogiatzis I; Ziakas A; Papadopoulos CΕ; Loutradis C; Imprialos KP; Stavropoulos K; Vasilikos V; Athyros VG; Karagiannis A; Doumas M; Papademetriou V
    Int J Cardiovasc Imaging; 2022 Nov; 38(11):2363-2372. PubMed ID: 36434346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic predictors of exercise intolerance in patients with heart failure with severely reduced ejection fraction.
    Zaborska B; Smarż K; Makowska E; Czepiel A; Świątkowski M; Jaxa-Chamiec T; Budaj A
    Medicine (Baltimore); 2018 Jul; 97(28):e11523. PubMed ID: 29995821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.